What we're reading, March 14, 2016: hospitals implement new ways to combat skyrocketing drug prices; some Affordable Care Act's health insurance co-ops could see profits in 2016; and patient anxiety decreases when hospitalists show more empathy.
Hospitals are beginning to implement new ways to combat rising drug prices and the burden these costs place on patients and the healthcare system. According to The Washington Post, hospitals are pulling drugs off “crash carts” after prices skyrocket or affixing a Zagat-like $ rating in the online system. The issue of increasing drug prices goes well beyond the incident with Turing Pharmaceuticals: some companies raised prices modestly but repeatedly for old and new medications, which has added up over time.
Although the Affordable Care Act’s health insurance co-ops lost millions in 2015, things might be able to change for the better for some in 2016. As they begin their third year of operation, the co-ops are adding customers, with enrollment growing better than expected, and their patient populations are getting younger, reported The New York Times. Some co-ops are expecting to see profits in 2016, but after this year a government program to help insurers pay big medical bills will come to an end.
There is a correlation between the empathy hospitalists show patients and the amount of anxiety those patients experience. Physicians responded with empathy just one third of the time, without empath one-fourth of the time and were neutral the rest of the time, according to Healio. Increased empathic responses were associated with better hospital and encounter ratings from the patient. However, emphatic responses were not associated with the length of patient encounter.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More